The Highest Standard in Peptide Research.

Bodytide Wellness Lab
WEIGHT MANAGEMENT & METABOLIC OPTIMISATION // HORMONE OPTIMISATION & VITALITY

GLP3 + FOLLISTATIN 344 31.2MG (DUO)

Advanced fat loss and muscle expansion

This premier dual-action blend combines GLP-3 (triple-hormone agonist) and Follistatin 344 (myostatin inhibitor) to accelerate fat loss while actively protecting and expanding lean muscle mass.

GLP3 + FOLLISTATIN 344 31.2MG (DUO)
£228.00

Active Ingredient: 31.20mg per pen

Volume: 3.00ml

For in vitro use only.

Typical research suggests 5 clicks daily, weeks 1-2. Then 10 clicks daily thereafter.

All our Peptide Pens are designed to last a minimum of 30 days.

Taxes included. Shipping calculated at checkout.

Current batch fully reserved. Next allocation underway.

Expected Benefits

By combining clinical research with day-to-day wellness support, this protocol offers clear metabolic improvements:

Triple-Pathway Fat Clearance: Drives rapid lipid oxidation via GLP-1, GIP, and Glucagon receptor agonism.
Accelerated Body Recomposition: Simultaneously reduces adipose volume while increasing lean structural muscle mass.
Appetite & Satiety Control: Calms persistent hunger signals in the brain to support dietary compliance.
Enhanced Metabolic Output: Upregulates basal metabolic rate and liver fat clearance.
Muscle Preservation: Blocks myostatin to prevent muscle loss during severe caloric deficits and promote muscle hypertrophy.

Manufactured and tested to
pharmaceutical standards

EU GMP ISO 9001 ISO 13485 ISO 14644
To maintain the integrity of your protocol, correct storage is essential. Always store your Peptide pen in its protective casing within the refrigerator, strictly between 2°C and 8°C. Ensure the pen is shielded from direct light and never allowed to freeze. When travelling, we recommend utilizing a temperature-controlled travel case.

What is GLP3 + FOLLISTATIN 344 31.2MG (DUO)?

This formulation combines two advanced research molecules: GLP-3 (a triple GLP-1/GIP/Glucagon agonist) and Follistatin 344 (a potent myostatin-binding protein). Together, they drive deep fat clearance while overriding the body's natural muscle-wasting signals during fat loss.

The Cellular Mechanism

Retatrutide Pathway: Agonizes GLP-1, GIP, and Glucagon receptors to slow gastric emptying, improve insulin sensitivity, and burn fat.
Follistatin 344 Pathway: Binds to and neutralizes myostatin and Activin A, unlocking muscle protein synthesis and stopping muscle breakdown.

Protocol Schedule

Clinical evaluation studies show that a typical research protocol ranges from 2.5mg to 5mg weekly. To ensure a smooth transition and allow cellular receptors to adapt comfortably, researchers follow a step-by-step escalation schedule:

Weeks 1–2 (Baseline Priming): An initial low introductory dose of 2.5mg once per week (25 clicks once per week).

Weeks 2 Onwards (Active Titration): The protocol scales to an intermediate level of 5mg twice per week (25 clicks twice per week).

Once target weight loss is achieved, dosage can be reviewed again.

Possible Side Effects

Digestive Adaptation: Mild, temporary nausea, indigestion, or changes in bowel habits as the system adapts to slower gastric emptying.
Satiety Pressure: A pronounced sensation of fullness or minor reflux.
Site Sensitivity: Minor, transient redness or warmth at the application site.